Company Filing History:
1 out of 340 
1 out of 39 
1 out of 832,880 Years Active: 2000-2002
Title: Edward Benjamin Jakobovits: Innovator in Immunoassay Technology
Introduction
Edward Benjamin Jakobovits is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of immunoassays, particularly through his innovative use of mutant glucose-6-phosphate dehydrogenases (G6PDH) as labels in various assays. With a total of 3 patents, Jakobovits has established himself as a key figure in the development of advanced diagnostic methods.
Latest Patents
Jakobovits' latest patents focus on homogeneous immunoassays utilizing mutant G6PDH enzymes. These inventions detail methods for immunoassaying analytes by employing conjugates of analytes or their analogs with mutant NAD-dependent G6PDH. The patents describe the construction of several mutations in precursor G6PDH enzymes, which typically involve the deletion or substitution of lysine residues or the introduction of cysteine residues. The inventions also encompass the development of kits, cell lines, DNA sequences, and vectors designed to facilitate the production of these subject enzymes.
Career Highlights
Throughout his career, Jakobovits has worked with various organizations, including Behringwerke Aktiengesellschaft. His work has significantly impacted the field of immunoassays, leading to advancements that enhance the accuracy and efficiency of diagnostic testing.
Collaborations
Jakobovits has collaborated with notable professionals in his field, including Joy L Silen and Mark J Levy. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
Edward Benjamin Jakobovits is a distinguished inventor whose work in immunoassay technology has paved the way for improved diagnostic methods. His contributions continue to influence the field and enhance the capabilities of modern medical testing.